This week, there is a whirlwind of bills targeting pharmacy benefit managers that are by turns similar and contradictory. The House is poised to pass a mental health bill with PBM transparency measures; the Senate Commerce Committee on Wednesday (June 22) passed a bipartisan PBM transparency bill; and a bipartisan Senate bill was introduced Wednesday that would undermine rebates for insulin. Despite those attacks on rebates, the bipartisan gun safety bill that was unveiled Tuesday, and that has the best...